La voix nationale de l’industrie pharmaceutique innovatrice canadienne.
As the Supreme Court's decision concluded, "the Promise Doctrine is incongruent with both the words and the scheme of the Patent Act."
By Joe Farago, Executive Director Healthcare Innovation at Innovative Medicines Canada It's tough to talk about mental illness
05/02/2017 03:01 EDT
Health care and drug coverage is often used as a political football, and coverage of medicines can make an easy and convenient target as a place to find short-term cost savings despite the need for a broader discussion on overall system reform.
01/17/2017 11:32 EST
One area where we can excel is in attracting more clinical trials to Canada. It fits extremely well into what our government is trying to do as we try to boost our economy. It also has the added value of making our publicly funded health-care system even better.
12/06/2016 11:16 EST
Online health information is valuable, but as one aspect of our decision making process, not as the sole source of information. Today's physician is an incredible resource -- a resource that understands the research we view online, remains current on the latest evidence, reads peer review journals and attends health conferences.
10/17/2016 01:59 EDT
There are more than 7,000 rare disorders and, by definition, each one of them impacts a small number of people. But overall, one in 12 Canadians suffers from a rare disease and about two-thirds of them are children. Adopting a strategy will give hope to many Canadian families who are struggling with the patchwork support systems throughout the country.
06/17/2015 05:27 EDT
SUBSCRIBE AND FOLLOW
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements. Learn more